Navigation Links
Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
Date:7/11/2012

to activate sites and conduct the Light Study; the potential for, and timing of, the accrual of MACE events and the potential resubmission of the Contrave NDA; the safety and effectiveness of Contrave; and the potential for, and timing of, approval for Contrave. The inclusion of forward-looking statements should not be regarded as a representation by Orexigen that any of its plans will be achieved. Actual results may differ from those set forth in this release due to the risk and uncertainties inherent in the Orexigen business, including, without limitation: the Special Protocol Assessment (SPA) is not binding on the FDA if public health concerns unrecognized at the time the SPA agreement was entered into become evident, other new scientific concerns regarding product safety or efficacy arise, or if Orexigen fails to comply with the agreed upon trial protocol; Orexigen's ability to conduct the Light Study and the progress and timing thereof, including risks associated with recruiting and enrolling patients in the Light Study; Orexigen's ability to demonstrate in the Light Study that the risk of MACE in overweight and obese subjects treated with Contrave does not adversely affect the product candidate's benefit-risk profile; the potential that earlier clinical trials may not be predictive of future results in the Light Study; the potential for the FDA to not approve Contrave even after the resubmission with the MACE event data; the potential for early termination of the collaboration agreement between Orexigen and Takeda; the costs and time required to complete additional clinical, non-clinical or other requirements prior to any resubmission of an NDA; the therapeutic and commercial value of Contrave; Orexigen's ability to maintain sufficient capital; and other risks described in the Company's filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof,
'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
4. NIPTE Will Participate in NIHs Therapeutics for Rare and Neglected Diseases (TRND) Program
5. Frost & Sullivan: European Bipolar Therapeutics Market Slows Down in the Short Term As Key Blockbuster Drugs Go Off Patent
6. Oncos Therapeutics Announces Clinical Advisory Board for its Oncolytic Virus and Cancer Immunotherapy Development Programs
7. The New Generation of Antibody Therapeutics: Current Status and Future Prospects - Overview
8. Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020
9. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
10. Novelos Therapeutics to Present at LHA Life Sciences & Medical Technologies Virtual Conference on June 28
11. Faruqi & Faruqi, LLP is Investigating Pain Therapeutics Inc. on Behalf of its Shareholders (PTIE)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... JOLLA, Calif. , June 1, 2015 /PRNewswire/ ... ), a biopharmaceutical company leading the discovery and ... that Kleanthis G. Xanthopoulos , Ph.D. has ... as a member of Regulus, Board of Directors, ... biotechnology industry.  Paul Grint, M.D., who previously served ...
(Date:6/1/2015)... N.C. , June 1, 2015  bioMérieux, a ... diagnostics, has been invited to join the White ... antibiotic use in the U.S. as a means to ... sectors, will gather tomorrow, June 2, 2015, to discuss ... five years to slow the emergence of antibiotic-resistant bacteria, ...
(Date:6/1/2015)... -- Select Medical Holdings Corporation (NYSE: SEM ) ... that Select Medical Corporation ("Select") formed with Welsh, Carson, ... acquisition of Concentra Inc.  Cressey & Company has also ... About Select Medical Corporation Select is ... clinics in the United States . ...
Breaking Medicine Technology:Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 2bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 3Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 2Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 3
... Research Foundation,s ADAPT-DES Study to Quantify Causes and Cures of Drug ... ... Corporation,(Nasdaq: VOLC ) [TCT Booth #2013 Level 2], a leading ... sponsorship of the first major study designed to,examine the role of ...
... results of the,first- ever randomized study to ... stent, with Boston Scientific,s Taxus drug-eluting,stent in ... efficacy at,30-day and six- month follow-up, reported ... director of the catheterization laboratory at,the Academic ...
Cached Medicine Technology:Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 2Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 3Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 4Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) and Boston Scientific's Taxus(R) Stent in Patients at High Risk of Restenosis 2
(Date:6/2/2015)... (PRWEB) June 02, 2015 SB 277 ... schedule for children to attend public or private school. ... Education but bypassed the Appropriations Committee (Sacramento Bee, May ... despite contentious hearings. , “We believe that this ... Exemptions (PBEs) more than it will (the) affect public ...
(Date:6/2/2015)... “We want men to realize the importance ... states Marta Phillips, owner of SunGrubbies.com, “that is why ... sun accessories that work well for outdoor activities.” , The ... sun damage can take up to thirty years to develop. ... for skin cancer to occur. That is why the ...
(Date:6/1/2015)... The National Association of Professional ... a 2015-2016 inductee into its VIP Woman of the ... for leadership in life coaching. NAPW is the nation’s ... than 700,000 members and over 200 operating Local Chapters. ... distinction,” said NAPW President Star Jones. “Her work as ...
(Date:6/1/2015)... City, NY (PRWEB) June 02, 2015 ... honors Linda Cade as a 2015-2016 inductee ... is recognized with this prestigious distinction for leadership in ... for professional women, boasting more than 700,000 members and ... recognize Linda with this important honor,” said NAPW President ...
(Date:6/1/2015)... Garden City, NY (PRWEB) June 02, 2015 ... honors Lenita F. Cornett, DSL, LSSBB (C), ... Inductee into its VIP Woman of the Year Circle. ... in the military. NAPW is the nation's leading networking ... members and over 200 operating Local Chapters. , “I'm ...
Breaking Medicine News(10 mins):Health News:A Voice For Choice Releases A Statement As SB277 Is Referred To Single Assembly Committee And Bypasses Education and Judicial Scrutiny 2Health News:It is Time to Show Father Who Knows Best, Says SunGrubbies.com, a Leading Online Sun Protection Retailer 2Health News:National Association of Professional Women Inducts Marcy Herrmann, Therapist, Life Coach, Advanced Handwriting Analyst, Into its VIP Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Linda Cade, Senior Product Manager at Sage, Into its VIP Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Lenita F. Cornett, First Sergeant of the US Military, Into its VIP Professional Woman of the Year Circle 2
... , , MIAMI, ... toys manufactured in China sent parents searching frantically for gifts ... refunds suggested that even so-called educational toys are suspect. Renowned ... are actually harmful to developing brains, retarding language development and ...
... , LONDON, Dec. 7 The National Health ... people in the UK, understands the value of an engaged ... initiative to improve the value of care, many NHS hospitals ... Tanner Company, to train hospital leaders. , "Staff engagement is ...
... , , BOCA RATON, ... the market leader in all-natural herbal and homeopathic remedies for ... as their PR firm of record. The company,s two brands, ... provide complete lines of safe, scientifically-tested, guaranteed products that promote ...
... ... has begun his work as the new worldwide executive director of the Drug Information ... ... MBA, CAE, officially has begun his work as the new worldwide executive director of ...
... , PARSIPPANY, N.J., Dec. 7 Today the Centers for ... Vaccination Week. While the week was designed to highlight the importance ... taking additional steps to keep you and your family healthy during ... , "It,s easy to get overwhelmed by all the information circulating ...
... may be able to reverse some of the damage to ... their cigarettes, according to research out of the University of ... in the December 15 issue of the American Thoracic Society,s ... "We found that exposure to cigarette smoke appears to ...
Cached Medicine News:Health News:Top 10 Toys That Will Scar Your Child for Life 2Health News:The NHS to Improve Patient Care by Better Engaging Staff 2Health News:Native Remedies and PetAlive.com Hires TransMedia Group to Herald Herbal for People and Pets 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 3Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 2Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 3Health News:Quitting smoking can reverse asthma-inducing changes in lungs 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: